Interpace Biosciences, Inc. is a molecular diagnostics company focused on cancer testing, primarily thyroid cancer. Its key products include ThyGeNEXT and ThyraMIR v2, molecular diagnostic tests for thyroid cancer. The company previously offered PancraGEN, a pancreatic cancer test, which lost Medicare reimbursement coverage effective April 24, 2025, leading to its discontinuance. Revenue is derived entirely from clinical diagnostic services.
Q2 FY2026 — expected 2026-08-04
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001493152-26-013646 | EDGAR | 65K words |
| 2025-03-31 | 2024-12-31 | 0001641172-25-001686 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012464 | EDGAR | — |
| 2023-03-27 | 2022-12-31 | 0001493152-23-009106 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001493152-22-008501 | EDGAR | — |
| 2021-04-01 | 2020-12-31 | 0001493152-21-007629 | EDGAR | — |
| 2020-04-22 | 2019-12-31 | 0001493152-20-006897 | EDGAR | — |
| 2019-03-21 | 2018-12-31 | 0001493152-19-003733 | EDGAR | — |
| 2018-03-23 | 2017-12-31 | 0001493152-18-003786 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001437749-17-005779 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001493152-25-021928 | EDGAR | 23K words |
| 2025-08-07 | 2025-06-30 | 0001641172-25-022591 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001641172-25-009275 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001493152-24-044265 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001493152-24-030772 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001493152-24-018432 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001493152-23-039909 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001493152-23-027295 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016658 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-032191 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022932 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001493152-22-013869 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-01 | 0001493152-26-014654 | EDGAR | 5K words |
| 2026-01-20 | 0001493152-26-002772 | EDGAR | — |
| 2025-12-03 | 0001493152-25-025960 | EDGAR | — |
| 2025-11-12 | 0001493152-25-021980 | EDGAR | — |
| 2025-08-08 | 0001641172-25-022774 | EDGAR | — |
| 2025-05-08 | 0001641172-25-009273 | EDGAR | — |
| 2025-05-01 | 0001641172-25-007944 | EDGAR | — |
| 2025-03-06 | 0001493152-25-009384 | EDGAR | — |
| 2025-01-27 | 0001493152-25-003797 | EDGAR | — |
| 2025-01-21 | 0001493152-25-003019 | EDGAR | — |
474 total filings indexed. 442 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001054102 |
| Ticker | IDXG |
| Exchange | OTC |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report